249 related articles for article (PubMed ID: 36383909)
1. Antibody-Drug Conjugates and Tissue-Agnostic Drug Development: An Update.
Dias E Silva D; Andriatte GM; Pestana RC
Cancer J; 2022 Nov-Dec 01; 28(6):462-468. PubMed ID: 36383909
[TBL] [Abstract][Full Text] [Related]
2. Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review.
Lambert JM; Morris CQ
Adv Ther; 2017 May; 34(5):1015-1035. PubMed ID: 28361465
[TBL] [Abstract][Full Text] [Related]
3. Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' Targetability.
Ascione L; Crimini E; Trapani D; Marra A; Criscitiello C; Curigliano G
Oncologist; 2023 Nov; 28(11):944-960. PubMed ID: 37665782
[TBL] [Abstract][Full Text] [Related]
4. Implementation of antibody-drug conjugates in HER2-positive solid cancers: Recent advances and future directions.
Yu J; Li M; Liu X; Wu S; Li R; Jiang Y; Zheng J; Li Z; Xin K; Xu Z; Li S; Chen X
Biomed Pharmacother; 2024 May; 174():116522. PubMed ID: 38565055
[TBL] [Abstract][Full Text] [Related]
5. Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2.
Schlam I; Moges R; Morganti S; Tolaney SM; Tarantino P
Crit Rev Oncol Hematol; 2023 Oct; 190():104090. PubMed ID: 37562695
[TBL] [Abstract][Full Text] [Related]
6. Antibody-drug conjugates: Principles and opportunities.
Phuna ZX; Kumar PA; Haroun E; Dutta D; Lim SH
Life Sci; 2024 Jun; 347():122676. PubMed ID: 38688384
[TBL] [Abstract][Full Text] [Related]
7. Antibody-drug conjugates in solid tumors: a look into novel targets.
Criscitiello C; Morganti S; Curigliano G
J Hematol Oncol; 2021 Jan; 14(1):20. PubMed ID: 33509252
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Drug Conjugates for Cancer Therapy.
Hafeez U; Parakh S; Gan HK; Scott AM
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081383
[TBL] [Abstract][Full Text] [Related]
9. Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload.
Kondrashov A; Sapkota S; Sharma A; Riano I; Kurzrock R; Adashek JJ
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631374
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for Antibody-Drug Conjugates in Solid Tumors.
Katrini J; Boldrini L; Santoro C; Valenza C; Trapani D; Curigliano G
Mol Cancer Ther; 2024 Apr; 23(4):436-446. PubMed ID: 38363729
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer.
Cherifi F; Da Silva A; Martins-Branco D; Awada A; Nader-Marta G
Expert Opin Drug Metab Toxicol; 2024; 20(1-2):45-59. PubMed ID: 38214896
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates.
Natangelo S; Trapani D; Koukoutzeli C; Boscolo Bielo L; Marvaso G; Jereczek-Fossa BA; Curigliano G
Crit Rev Oncol Hematol; 2024 Mar; 195():104270. PubMed ID: 38272150
[TBL] [Abstract][Full Text] [Related]
13. Novel antibody-drug conjugates: current and future roles in gynecologic oncology.
Tymon-Rosario J; Zeybek B; Santin AD
Curr Opin Obstet Gynecol; 2021 Feb; 33(1):26-33. PubMed ID: 32618744
[TBL] [Abstract][Full Text] [Related]
14. Drug-conjugated antibodies for the treatment of cancer.
Lambert JM
Br J Clin Pharmacol; 2013 Aug; 76(2):248-62. PubMed ID: 23173552
[TBL] [Abstract][Full Text] [Related]
15. Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
Peters C; Brown S
Biosci Rep; 2015 Jun; 35(4):. PubMed ID: 26182432
[TBL] [Abstract][Full Text] [Related]
16. Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors.
Nelson BE; Meric-Bernstam F
Annu Rev Med; 2024 Jan; 75():31-48. PubMed ID: 37758237
[TBL] [Abstract][Full Text] [Related]
17. Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in Oncology.
Lordick F; Merz M; Büch E; Aigner A
Dtsch Arztebl Int; 2023 May; 120(19):329-336. PubMed ID: 37073718
[TBL] [Abstract][Full Text] [Related]
18. Stepping forward in antibody-drug conjugate development.
Jin Y; Schladetsch MA; Huang X; Balunas MJ; Wiemer AJ
Pharmacol Ther; 2022 Jan; 229():107917. PubMed ID: 34171334
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates.
Lu N; Wu J; Tian M; Zhang S; Li Z; Shi L
Eur J Med Chem; 2024 Mar; 268():116233. PubMed ID: 38408390
[TBL] [Abstract][Full Text] [Related]
20. Exploring the next generation of antibody-drug conjugates.
Tsuchikama K; Anami Y; Ha SYY; Yamazaki CM
Nat Rev Clin Oncol; 2024 Mar; 21(3):203-223. PubMed ID: 38191923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
